Cingulate (CING) Liabilities and Shareholders Equity (2021 - 2026)
Cingulate's (CING) quarterly Liabilities and Shareholders Equity came in at $33.1 million in Q2 2026, up 119.37% quarter-over-quarter from $15.1 million in Q4 2025.
Powered by 
Analysis
Cingulate (CING) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Cingulate (CING) has reported Liabilities and Shareholders Equity for 6 consecutive years, with $33.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $33.1 million; the trailing twelve-month figure through Jun 2026 stood at $58.7 million (up 43.37% YoY), and the FY2025 full-year result was $15.1 million, up 1.4% from the prior year.
- Liabilities and Shareholders Equity rose to $33.1 million in Q2 2026 per CING's latest filing, from $15.1 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $33.1 million in Q2 2026 and bottomed at $3.5 million in Q4 2023.
- Historically, Liabilities and Shareholders Equity has averaged $11.9 million across 5 years, with a median of $11.9 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity sank 69.39% in 2023, then soared 325.74% in 2024.
- Over 5 years, Liabilities and Shareholders Equity stood at $11.4 million in 2022, then tumbled by 69.39% to $3.5 million in 2023, then jumped by 325.74% to $14.9 million in 2024, then climbed by 1.4% to $15.1 million in 2025, then soared by 119.37% to $33.1 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $33.1 million, $15.1 million, and $10.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 201.13 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 87.63 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 150.01 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 4.32 Bn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 9.18 Bn |
| 10 | Cingulate | 72.81 Mn | 72.81 Mn | - | 33.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.07 Mn |
| Dec 31, 2025 | 15.07 Mn |
| Sep 30, 2025 | 10.52 Mn |
| Mar 31, 2025 | 12.47 Mn |
| Dec 31, 2024 | 14.86 Mn |
| Sep 30, 2024 | 13.58 Mn |
| Jun 30, 2024 | 5.13 Mn |
| Mar 31, 2024 | 5.49 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Sep 30, 2023 | 5.87 Mn |
| Jun 30, 2023 | 5.23 Mn |
| Mar 31, 2023 | 7.16 Mn |
| Dec 31, 2022 | 11.41 Mn |
| Sep 30, 2022 | 15.38 Mn |
| Jun 30, 2022 | 13.80 Mn |
| Mar 31, 2022 | 18.43 Mn |
| Dec 31, 2021 | 22.89 Mn |
API Access
Cingulate Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CING&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CING", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CING&period=max&api_key=YOUR_API_KEY");
const data = await res.json();